Shree Ram Proteins Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on March 05, 2026
Awaiting price reaction for this filing.
Shree Ram Proteins Limited held an Extraordinary General Meeting (EGM) on March 5, 2026, conducted via video conferencing. Two ordinary resolutions were transacted through remote e-voting. The first resolution sought shareholder approval for the sale of the undertaking/company as a material related party transaction under Section 188 of the Companies Act, 2013, and Regulation 23 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The second resolution aimed to raise capital through a Qualified Institutions Placement (QIP) by issuing equity shares or other eligible securities to qualified institutional buyers. Directors present included Chairman and Managing Director Lalitkumar Chandulal Vasoya, along with Directors Navin Kumar Singh and Piyush Chandubhai Vasoya. M/s Payal Dhamecha & Associates was appointed as scrutinizer to oversee the e-voting process. The detailed voting results will be submitted separately to the exchanges.
Shareholders should note two significant items requiring their approval: a potential sale of the company/undertaking to a related party and a proposed capital raise via QIP. The outcome of these resolutions could materially impact the company's ownership structure, future direction, and shareholder dilution. Investors should await the voting results for clarity on shareholder sentiment.